Wednesday, February 27, 2019

Men and Muscle Relaxing Injections

According to a new study in the journal Cosmetic Dermatology, the number of Americanmen getting Botox injections—which relax the facial muscles to minimize..

Monday, February 25, 2019

Patrick Treacy 

Winner ‘Aesthetic Doctor of the Year’ 201 Chairman Royal Society of Medicine (Lon) International Society of Medicine aker. Educator, Author 'Behind The Mask'

Royal Society of Medicine Research Award for poster submissions relating to the combined use of PRP, Stem Cells and 633nm red light to regenerate epithelial tissue

Tuesday, February 12, 2019

Dr. Patrick Treacy addresses AIDA 2018 Conference in Abu Dhabi on the 'Theory of Facial Aging and Subsequent Management.

Original theories behind facial aging have focused on soft-tissue laxity, ptosis, and descent of the envelope over time on account of gravity. Anatomical observational studies evaluating skeletal morphological changes of the midface, mandible, and orbit over time by authors such as Hellman, Lambros et al, Pessa et al, and Shaw and Langstein et al confirm bony facial remodeling over the course of one’s life

Monday, February 4, 2019

Allergan angling to stop U.S. sales of Botox competitor

|About: Allergan plc (AGN)|By:, SA News Editor 
Allergan (AGN -0.1%) and development partner Medytox have filed a complaint with the U.S. International Trade Commission aimed at stopping the market launch of a competitor to top seller Botox. The product, DWP-450, developed by South Korea's Daewoong Pharmaceuticals and licensed to Evolus (EOLS +3.3%), is expected to be approved by the FDA any time (specific action date is Saturday). If approved, Evolus is expected to launch it at a price about 25% below Allergan's.
South Korea-based Medytox claims that a former employee gave Daewoong the results of its research on a new manufacturing process for the botulinum toxin. The latter markets its product in South Korea under the brand name Nabota and plans to sell it elsewhere under the name Jeuveau.
Allergan and Medytox are working on a next-generation drug but it will not be approved in the U.S. until 2022.
Litigation in Korea between Medytox and Daewoong is ongoing. Apparently, there is also a criminal investigation into Daewoong and the former Medytox employee.                                                    

Thursday, January 31, 2019

An investigation by the ABC's Four Corners last year revealed Australian doctors had treated their first patient who had gone permanently blind from having dermal filler injected into her face. The investigation found 98 documented cases of blindness caused by fillers.

"Cosmetic injectables are medical procedures that carry risks and these need to be weighed up with the perceived physical and psychological benefits.
"You should make sure you go to a clean and fully-sanitised clinic and see an experienced practitioner, who knows what to do if there is a complication, this is particularly important in remote areas." 
The WA Department of Heath said cosmetic clinics who hire rooms in salons must hold a Health Service permit.
The permit requires all locations where treatments take place to meet professional standards for medical procedures.
The department said cosmetic injections and treatments can result in serious unwanted effects, including blood clots, skin necrosis (premature skin death) and blindness, although it said they are rare.
Other serious adverse effects include severe infections, allergic reactions, severe bruising, disfigurement, scarring and muscle weakness.
An investigation by the ABC's Four Corners last year revealed Australian doctors had treated their first patient who had gone permanently blind from having dermal filler injected into her face.
The investigation found 98 documented cases of blindness caused by fillers.
The Australasian Foundation for Plastic Surgery says no one knows how many cosmetic procedures are being performed in Australia or New Zealand, as statistics are not being collected.
This is because cosmetic surgery can be elective and a range of different practitioners perform procedures, from specialist plastic surgeons to dermatologists.

Friday, January 25, 2019

Vegan Millenials refuse Botox

The main ingredient in Botox is botulinum toxin, produced by Clostridium botulinum bacteria.  Although the main ingredient in Botox comes from bacteria, since another ingredient is from humans, 
Botox is not vegan.

 Not only is Botox made of a non-vegan ingredient, the injectable is also tested on animals.

Botox and Fillers. As most fillers, including lip and derma fillers, are made from non-animal origin hyaluronic acid, they are considered vegan
However, much like Botox, they are required by law to be tested on animals because they're classified as medical products.

Anyone born between 1981 and 1996 (ages 23 to 38 in 2019) is considered a Millennial

Wednesday, January 23, 2019

Are you a good candidate for fillers?

The following are some common reason why you may want to consider fillers:
  • You have lines or wrinkles around your mouth, eyes or forehead.
  • You’d like to enhance the volume in areas such as the cheeks, jaw line or lips.
  • If you have scars and depressions in the skin resulting from acne, injury or congenital imperfections.

  1. Injectable fillers can help diminish the appearance of deep nasolabial lines.
  2. Adding volume to areas like the cheekbones can create a more defined contour.

Tuesday, January 22, 2019

What is hyaluronic acid

Naturally present in the skin, hyaluronic acid maintains its hydration levels and contributes to its tone. It is a potent moisturising agent with a capacity to retain up to 1,000 times its weight in water.

 The amount of hyaluronic acid in the dermis gradually decreases with age. As a result, the skin becomes dry and fragile and the first wrinkles appear. When it is injected into the dermis, Teosyal effectively compensates for this deficiency due to its high hyaluronic acid concentration.

Friday, January 11, 2019

How is Dermal Filler Different to Botox?

 by Dr Timothy Beazleigh

How is Dermal Filler Different to Botox?

People are often confused by the difference between Botox and dermal filler treatments, assuming they are the same. Whilst Botox is a muscle relaxant and is used to minimise muscle contraction thus reducing fine lines and wrinkles on facial movement, dermal filler is used specifically to restore volume to deeper, lines, creases and folds that are usually static i.e. permanently visible on the face even when the face isn’t moving.

Traditional areas to treat with standard dermal fillers – including Juvederm and Restylane – are the nasolabial folds (corner of the nostrils to corners of the mouth), marionette lines (corners of mouth to chin/jowls) and the smokers lines (above the top lip). Thicker, more volumising fillers including Juvederm Voluma are used specifically to the mid face region to augment cheek bones, restore volume and plumpness to the lower cheeks and redefine the chin and temples. Fillers are also used to enchance and recontour lips.

As a treatment with dermal fillers requires the needle to penetrate the dermis deeper than for a standard Botox treatment, there is usually more opportunity for bruising to occur as the blood vessels are not visible to the practitioner (beyond the superficial layer), but bruising is by no means a standard side effect and occurs in approximately 50% of treatments.

Juvederm is the filler of choice at Melior Clinics Botox & Facial Aesthetic London Clinic as, being monophasic, it is smooth in consistency and also contains a built in anaesthetic, making the process a lot more comfortable for the patient.